These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 209764)

  • 1. Comments on the immunizing capicity of B. pertussin serotypes.
    Andreescu V; Caffé I; Marion M; Ivan I
    Arch Roum Pathol Exp Microbiol; 1977; 36(2):107-14. PubMed ID: 209764
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the serologic type in experimental immunity against B. Pertussis.
    Pusztai Z; Joó I
    Prog Immunobiol Stand; 1967; 3():309-14. PubMed ID: 4314431
    [No Abstract]   [Full Text] [Related]  

  • 3. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of Bordetella strains used in the production of anti-pertussis vaccine in stationary culture].
    Castillejos Carmona R; González Pacheco M
    Salud Publica Mex; 1981; 23(6):549-53. PubMed ID: 6278653
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of Bordetella pertussis preserved in liquid nitrogen as a challenge suspension in the Kendrick mouse protection test.
    Novotny P; Brookes JE
    J Biol Stand; 1975; 3(1):11-29. PubMed ID: 165201
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis.
    Preston NW; Surapatana N; Carter EJ
    J Hyg (Lond); 1982 Feb; 88(1):39-46. PubMed ID: 6276465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype specificity of vaccine-induced immunity to pertussis.
    Preston NW; Carter EJ
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential immunogens in human pertussis: the role of fimbriae.
    Preston NW
    Dev Biol Stand; 1985; 61():137-41. PubMed ID: 2872099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 14. An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands.
    van Gent M; de Greeff SC; van der Heide HG; Mooi FR
    Vaccine; 2009 Mar; 27(13):1898-903. PubMed ID: 19368769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis component vaccine in Japan.
    Preston NW
    Lancet; 1984 Feb; 1(8374):456. PubMed ID: 6142187
    [No Abstract]   [Full Text] [Related]  

  • 16. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
    Sakurai S; Kamachi K; Konda T; Komuro K; Uchida T
    Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and histological reactions to respiratory administration of ribosomal Bordetella pertussis vaccine in mice.
    Bartlema HC; Braunius R
    Z Erkr Atmungsorgane; 1979 May; 153(2):254-60. PubMed ID: 232799
    [No Abstract]   [Full Text] [Related]  

  • 18. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of acellular pertussis vaccine by assay of serum neutralizing antibodies to pertussis toxin (antitoxin): analogy with diphtheria toxoid.
    Robbins JB; Schneerson R; Trollfors B; Taranger J; Lagergård T
    Dev Biol Stand; 1998; 95():155-8. PubMed ID: 9855426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine-sensitising factor of Bordetella pertussis differentiated from immunogens by neutralisation and passive protection tests.
    Preston NW; Garrity P
    J Pathol Bacteriol; 1967 Apr; 93(2):483-92. PubMed ID: 4293307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.